|
|
||||||||
2+ TCR
+ T Lymphocytes from Healthy Donors and Multiple Sclerosis Patients1





*
Laboratorio Immunopatologia, Istituto Nazionale per la Ricerca sul Cancro e Centro Biotecnologie Avanzate (IST-CBA), Genoa, Italy;
Laboratorio Immunologia dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Milan, Italy;
Laboratorio Neuroimmunologia, Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia, Rome, Italy;
§
Dipartimento di Neuroscienze "Lancisi," Ospedale S. Camillo, Rome, Italy;
¶
Dipartimento di Scienze Neurologiche, Universita "La Sapienza," Rome, Italy; and
||
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY

T lymphocytes are thought to play a role in the pathogenesis
of multiple sclerosis (MS) contributing to demyelinization and fibrosis
in the central nervous system. In this study, we show that, in MS
patients with active disease, the percentage of circulating
V
2+ 
T cells coexpressing NKRP1A is significantly
increased compared with healthy donors. V
2+ and
V
1+ T cells were sorted from MS patients and healthy
volunteers and cloned. At variance with V
1+ clones, all
V
2+ clones expressed NKRP1A, which was strongly
up-regulated upon culture with IL-12; this effect was neutralized by
specific anti-IL-12 Abs. No up-regulation of NKRP1A by IL-12 was
noted on V
1+ clones. RNase protection assay showed that
IL-12R ß2 subunit transcript was significantly less represented in
V
1+ than V
2+ clones. This finding may
explain the different effect exerted by IL-12 on these clones. In
transendothelial migration assays, V
2+
NKRP1A+ clones migrated more effectively than
V
1+ clones, and this migratory potential was enhanced
following culture with IL-12. Migration was strongly inhibited by the
F(ab')2 of an anti-NKRP1A Ab, suggesting that this
lectin is involved in the migration process. We also show that, in
freshly isolated PBMC from MS patients, the migrated population was
enriched for V
2+ NKRP1A+ cells. We conclude
that the expression of NKRP1A on V
2+ cells is associated
with increased ability to migrate across the vascular endothelium and
that this phenomenon may be regulated by IL-12 present in the
microenvironment.
This article has been cited by other articles:
![]() |
L. Cosmi, R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor J. Exp. Med., August 4, 2008; 205(8): 1903 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Rosen, J. Bettadapura, M. Alsharifi, P. A. Mathew, H. S. Warren, and L. L. Lanier Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor J. Immunol., December 15, 2005; 175(12): 7796 - 7799. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vignard, B. Lemercier, A. Lim, M.-C. Pandolfino, Y. Guilloux, A. Khammari, C. Rabu, K. Echasserieau, F. Lang, M.-L. Gougeon, et al. Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells J. Immunol., October 1, 2005; 175(7): 4797 - 4805. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Conti, R. Casetti, M. Cardone, B. Varano, A. Martino, F. Belardelli, F. Poccia, and S. Gessani Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated {gamma}{delta} T Cells: Role of CD86 and Inflammatory Cytokines J. Immunol., January 1, 2005; 174(1): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Poggi, R. Carosio, D. Fenoglio, S. Brenci, G. Murdaca, M. Setti, F. Indiveri, S. Scabini, E. Ferrero, and M. R. Zocchi Migration of V{delta}1 and V{delta}2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat Blood, March 15, 2004; 103(6): 2205 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Warrington, A. N. Vallejo, C. M. Weyand, and J. J. Goronzy CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation Blood, May 1, 2003; 101(9): 3543 - 3549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Poggi, M. R. Zocchi, R. Carosio, E. Ferrero, D. F. Angelini, S. Galgani, M. D. Caramia, G. Bernardi, G. Borsellino, and L. Battistini Transendothelial Migratory Pathways of V{delta}1+TCR{gamma}{delta}+ and V{delta}2+TCR{gamma}{delta}+ T Lymphocytes from Healthy Donors and Multiple Sclerosis Patients: Involvement of Phosphatidylinositol 3 Kinase and Calcium Calmodulin-Dependent Kinase II J. Immunol., June 15, 2002; 168(12): 6071 - 6077. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Derre, M. Corvaisier, M.-C. Pandolfino, E. Diez, F. Jotereau, and N. Gervois Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy J. Immunol., May 15, 2002; 168(10): 4864 - 4870. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cipriani, G. Borsellino, F. Poccia, R. Placido, D. Tramonti, S. Bach, L. Battistini, and C. F. Brosnan Activation of C-C beta -chemokines in human peripheral blood gamma delta T cells by isopentenyl pyrophosphate and regulation by cytokines Blood, January 1, 2000; 95(1): 39 - 47. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |